Evaluation of Recombinant Human Platelet Derived Growth Factor- BB in Healing of Chronic Diabetic Foot Ulcers

Journal Title: International Journal of Contemporary Medical Research - Year 2017, Vol 4, Issue 7

Abstract

Introduction: Diabetic foot problems are common throughout the world resulting in major economic consequences. Once a wound developed in diabetics it remains open for prolonged periods. Senescent and altered resident cells and certain growth factors deficiencies are incriminated for chronicity of wound. Growth factors are biologically active polypeptides that act to alter growth, differentiation and metabolism of targets cells. The present study was conducted with the aim to compare the effects of exogenous application of PGDF (platelet derived growth factor) on ulcer healing rate. Material and Methods: All patients of age group 18-80 yrs with diabetic foot ulcer of more than 4 weeks duration were taken. Patients were randomised to one of two parallel treatment groups. In group 1, standard wound Care was given. Second group was treated with local applications of recombinant human PDGF-BB along with the required wound care. Primary study end points were complete healing of ulcers,12 weeks of duration, ulcer bed adequate for possible skin closure /skin grafting. Results: Average time taken to achieve ulcer closure/skin cover at 12 weeks duration in PDGF group (38.5 days) was found to be less than in GWC (good wound care) group (63 days). Incidence of ulcer closure/skin cover at 12 weeks in patients with age less than 60 years (66.66) and non-smokers (68.18%) was found to be more than in patients with age more than 60 yrs or smokers(21.43%). Conclusion: The incidence of ulcer closure / skin cover at 12 weeks duration in PDGF group was found to be more than in GWC group and this difference was statically significant.

Authors and Affiliations

Vishal Mandial, Money Gupta, Renuka Sharma

Keywords

Related Articles

Discuss the Role of Screening for Diabetes in our Community and which Test would be Cost-Effective

Chronic degenerative diseases represent the major challenge to public health in the 21st century. Having largely conquered epidemic infectious diseases, in future diabetes and cardiovascular disease, and their underlying...

Progressive Craniofacial Abnormality in a Case of Congenital Neurofibromatosis

Introduction: Neurofibromatosis is a generalized form of benign tumour of peripheral nerves, from fibrous element of nerve sheath. There are two types of neurofibromatosis, both being autosomal dominant. Type 1 also know...

Immunohistochemical Staining by TTF-1 and P63 Markers for Typing of Non Small Cell Lung Carcinomas: A Three Year Study of A Tertiary Care Health Centre

Introduction: Studies have shown that selection of therapies such as vascular endothelial growth receptor (VEGR) and epithelial growth factor receptor (EGFR) inhibitors may depend on the correct differentiation of squamo...

Urinary Stones, Renal Cysts and Renal Impairment in Patients with Gout

Introduction: Urinary stones, renal cysts and renal failure are reported complications of gout. This study aimed to elucidate prevalence and relationship among them in gout patients. Material and Methods: In this prospec...

Knowledge of Osteoporosis and its Risk Factors among Nursing Staff of a Tertiary Care Hospital

Introduction: Osteoporosis is being reported as a major cause of morbidity among elderly individuals in India. Osteoporotic fracture rates in India are among the highest in Asia. Nursing professionals are the key link in...

Download PDF file
  • EP ID EP427106
  • DOI -
  • Views 103
  • Downloads 0

How To Cite

Vishal Mandial, Money Gupta, Renuka Sharma (2017). Evaluation of Recombinant Human Platelet Derived Growth Factor- BB in Healing of Chronic Diabetic Foot Ulcers. International Journal of Contemporary Medical Research, 4(7), 1607-1610. https://europub.co.uk/articles/-A-427106